Science now supports several mind-body interventions - meditation, yoga, acupuncture, music therapy, for example- and a Wilmot faculty member was on the national panel.
Groundbreaking research shows that a longevity gene can be transferred from one mammal to another to extend life and stave off aging-related diseases like cancer.
Karen Mustian, PhD, MPH, tenured dean’s professor in the Division of Cancer Control, Department of Surgery, and a longtime leader at the Wilmot Cancer Institute, has been promoted to Associate ...
In the latest edition of Dialogue (Vol 1, 2023), read stories about breast cancer care and research at Wilmot Cancer Institute, a community collaboration that is benefitting cancer research, and ...
Thanks to a groundbreaking nationwide study with Wilmot Director Jonathan Friedberg at the helm, a practice-changing treatment emerged for young people with Hodgkin lymphoma.
Christine Skivington was honored at Wilmot Cancer Institute’s annual Discovery Ball on May 6, 2023, for her inspiring story. She is the mother of three small children who faced an aggressive type of ...
Life-extending immunotherapies, like CAR T-cell cancer therapy, sometimes migrate to places they shouldn’t go. A Wilmot team discovered the molecule that guides T cells toward tumors, setting the ...
Polypharmacy is a buzz word for the use of multiple medications. A Wilmot Cancer Institute study shows it can have serious consequences for older adults with cancer.
Melissa Selner, 38, and her mother, Alice Pena, 71, practically finish each other’s sentences and have been close throughout life. During the last two years, they added breast cancer to their shared ...
Anna Weiss, MD, recently joined Wilmot Cancer Institute as a breast cancer surgeon and director of the Breast Cancer Service Line. A Syracuse native, she shares her vision for Wilmot's Breast Care ...
The area around Wilmot Cancer Institute has a much higher rate of lung cancer compared to New York state and the rest of the U.S. Wilmot is working to address this statistic through prevention, ...
Lung cancer weighs heavy in the Rochester region and Wilmot Cancer Institute has multi-pronged strategies to meet the challenge. Read about the data behind lung cancer cases in the region, early ...
In a new study, the majority of individuals treated as children for Hodgkin lymphoma who are now in their 30s, showed signs of being an average of 7.7 years older biologically than their peers.
Recent reports raised questions about colonoscopy, but don't cancel your procedure because it's still the best way to prevent and detect colorectal cancer.
A simple blood test can predict cancer in people who have a lesion or cyst in the pelvic region, according to a new study in the Obstetrics & Gynecology "Green" journal. The non-invasive test, which ...
New technology and new guidance from two studies help to identify cancer earlier, track it when it's already present, and clarify gray areas of concern.
Three Wilmot investigators won a Cancer Grand Challenges grant and will work with a global team to study cachexia, a debilitating condition associated with cancer. The team awards were announced ...
During this graduation season, here's some nice "firsts" — Carlos Ortiz-Bonilla, Ph.D., is the first to complete a new cancer biology concentration and the first in his family to earn an advanced ...
Taking multiple prescription drugs and supplements can be fraught with risk, a new study suggests - but it's hard for many people to part with their medications.
Eric Snyder says he’s “out to change the world” — and he’s only half joking. At the very least, the director of Informatics at Wilmot Cancer Institute wants to change the nation’s thinking around ...
Twelve years ago, three women were separately in search of camaraderie as their families were shaken by pancreatic cancer. They had joined a popular nationwide online discussion forum, and to their ...
Building a more diverse workforce means reaching out to bright minds and persuading them to embrace the prevention, diagnosis, and treatment of cancer. Wilmot’s associate director for the Cancer ...
In September 2021, Wilmot Cancer Institute met a goal set five years ago: To apply to the National Cancer Institute for a P30 Cancer Center Support Grant (CCSG). In the following Q&A story, Wilmot ...
At 23 years old, Scott Gerber was a cashier at Dunkin Donuts and admittedly “lost” in a master’s program at the URMC. But he took a risk based on an interest in immunology - and it led to a ...
Doctors can safely prescribe less chemotherapy for older adults without impacting survival, if personal circumstances call for it. A tool known as geriatric assessment helps to determine the correct ...
Many small business growth stories — whether it involves a food retailer, a fashion brand, or even Zoom, which was much less known until 2019 — have things in common with the Wilmot Cancer ...
By integrating pharmacists into the inpatient and outpatient clinical teams, Wilmot Cancer Institute is part of a national trend in oncology. Pharmacists act as watchdogs for treatment decisions and ...
Read the 2021 edition of Dialogue, a magazine for community supporters of the Wilmot Cancer Institute. Filled with inspiring stories about patients and the talented people who work at Wilmot.
Wilmot investigators discovered that frailty is linked to inflammation in cancer patients, and wonder if reducing inflammation prior to treatment will help patients live better and stronger.
Women who are being treated for breast cancer, were recently treated, or have survived the disease, should get the COVID vaccine as soon they can, according to Carla Falkson, M.D. She addressed the ...
Zinc is an essential mineral used as a sunscreen and to boost the immune system. At the cellular level, another form of zinc may help to prevent most cancers.
Wilmot researchers helped to develop a risk tool that found eight key predictors of whether chemotherapy side effects were likely to be minimal or severe for older adults.
Karen Kugel, R.N., a URMC oncology nurse for 30 years, recently released a small study, reported by the Oncology Nursing Society, that showed it is possible to control pain after gynecologic surgery ...
Laura Calvi, M.D., achieved what a lot of translational researchers only dream of: For years, she made important discoveries in the lab, but then she was able to turn the project into a clinical ...
Congratulations to all Wilmot Cancer Institute physicians and researchers who were invited to present data at the ASH annual meeting, taking place virtually on Dec. 5 through 8, 2020.
Patrick Reagan, M.D., looks at the data on his computer screen and a rare grin spreads across his face. His most recent study results for patients with end-stage mantle cell lymphoma show that an ...
In autumn of 2017, Nicole Zaleski-Conine experienced side effects she chalked up to a host of reasons, but in January 2018, the definitive diagnosis came in: follicular lymphoma that transformed into ...
Maxine and Dave Wilson finish each other’s sentences. They feel blessed to have each other, given what Maxine has been through. Then, Maxine was unexpectedly diagnosed with non-Hodgkin lymphoma in ...
Patrick Brophy, M.D., physician-in-chief at UR Medicine Golisano Children’s Hospital, says he never looked at his own medical chart. But he knew his health was declining rapidly.
It’s best to avoid common pain relievers after a flu shot because they can dilute the power of the vaccine, according to research conducted at the University of Rochester Medical Center.
Wilmot Cancer Institute leadership has enlisted bright minds from across the nation to come here, to Rochester, as part of a team that pledges to defeat cancer.
Working with zebrafish, Patrick Murphy, Ph.D., wants to understand some of the most fundamental questions in cancer including how cells divide and change inappropriately.
Stephano Mello, Ph.D., has always lived for those “eureka” moments in the lab, but it was a series of personal eureka moments that shifted him toward cancer research.
After a friend died of breast cancer at age 34, Isaac Harris, Ph.D., felt the urgency of his work to better understand how cancer cells grow and resist treatment.
Ian Kleckner, Ph.D., M.P.H., has always found the mind-body connection fascinating, and today, his work focuses on discovering whether exercise may help with a common cancer treatment side effect: ...
Michael Giacomelli, Ph.D., has two babies: His daughter, born just as he was setting up his lab in Rochester, and a prized invention, a novel 3D imaging device that helps surgeons detect whether a ...
Ben Frisch, Ph.D., grew up on a dairy farm and is no stranger to hard work. As a researcher, he’s working to understand how cancer impacts healthy bone marrow.
His interest in science started at a young age, and today Thomas Ciucci, Ph.D., wants to better understand T-cells, in hopes of making them better fighters against cancer.
Despite humble beginnings, today, Jeevisha Bajaj, Ph.D., uses some of the most sophisticated tools – including CRISPR technology – to study blood cancers.
The cutting-edge microscope is the first of its kind in the Rochester region, and a boon for cancer researchers such as Laura Calvi and Clara Kielkopf.
Vapers, smokers, and non-smokers with chronic conditions such as high blood pressure or diabetes are all at higher risk for contracting COVID-19. The scientific explanation behind this is complex and ...
As one of the most distinguished surgeons in America, Seymour I. Schwartz, M.D., edited and co-wrote the textbook used to teach generations of young doctors and led the surgical societies that shaped ...
A new University of Rochester Medical Center study aims to reduce the screening disparity for cervical cancer, a highly preventable disease, with a study conducted at UR Medicine emergency ...
While other cancer researchers had to temporarily close their labs in March due to the COVID-19 pandemic, Isaac Harris, Ph.D., and Josh Munger, Ph.D., shifted their focus to the contagion that has ...
David Linehan, M.D., chief of clinical operations at the Wilmot Cancer Institute, is the inaugural recipient of a $1.5 million award from Gateway for Cancer Research.
Karen Mustian, Ph.D. and Supriya Mohile, M.D. Three Wilmot Cancer Institute researchers received a highly-valued type of National Cancer Institute award that supports team science, a strategy ...
Genetic tests for cancer helps doctors and patients figure out the best targeted therapy matched to the tumor’s mutations. But the tests leave questions hanging about radiation therapy — until now.
The drug ibrutinib is a highly effective treatment for people with chronic lymphocytic leukemia (CLL), but a new Wilmot Cancer Institute study shows that weight gain, as a drug side effect, should be ...
A pacemaker-like device restored heart function in a group of cancer survivors — mostly women with breast cancer — who had suffered from heart failure as a result of chemotherapy, a study in the ...
A Wilmot Cancer Institute-led study in JAMA Oncology shows that when physicians fully appreciate the concerns of older adults with cancer, such as function and forgetfulness, it elevates patient care ...
Melissa (Kah Poh) Loh, M.D., a senior instructor at the Wilmot Cancer Institute, has received $1 million to study a mobile exercise app for older patients with cancer. The project will likely ...
Pain, nausea, and shortness of breath are the most common reasons that cancer patients seek emergency treatment, according to a nationwide analysis including the Rochester area and patients from the ...
A Wilmot Cancer Institute research team reports that combining a type of radiation therapy with immunotherapy not only cures pancreatic cancer in mice, but appears to reprogram the immune system to ...
UR Medicine’s Wilmot Cancer Institute is continuing its practice-changing research into cancer side-effects and symptom management with a coveted $29 million grant from the National Cancer ...
T-cell immunotherapy is a revolutionary treatment that harnesses a patient’s own immune cells to kill cancer. A Wilmot Cancer Institute scientist received a $2.8 million award to investigate the ...
Manny Tuccio, a 53-year-old husband and father of three, has a striking family history of bladder cancer. When he was diagnosed himself, however, his luck started to change because a research boom ...
A blood test to detect tumor cells in women suspected of having ovarian cancer has been fine-tuned and evaluated in a pilot study, and now the Wilmot Cancer Institute expects to launch a larger ...
The National Institute on Aging awarded $1.2 million to Allison Magnuson, D.O., as part of an effort to support talented physicians and scientists who are expected to lead the next generation in ...
Meet Paula Vertino, Ph.D., the Wilmot Distinguished Professor in Cancer Genomics, and the cancer institute’s highest-level leadership recruit in several years.
A Wilmot Cancer Institute researcher has launched an innovative new study, combining radiotherapy and immune therapy as a way to attack pancreatic cancer, a disease known for its dismally low ...
Wilmot Cancer Institute scientists believe they have figured out why a commonly used drug to treat late-stage prostate cancer stops working after four or five months and appears to have a dual ...
A Wilmot Cancer Institute scientist developed a new way to study how bladder cancer spreads and to investigate potential new treatments. The tool, which is described in a top medical journal, ...
As the body ages so does the blood, raising the risk of leukemia and other blood cancers. A recent Wilmot Cancer Institute discovery showed a new way in which blood degrades when inflammation ...
Families of cancer patients described three distinct experiences — “We Pretty Much Knew,” “Beating the Odds,” and “Left to Die” — in the final weeks of their loved one’s life. Wilmot Cancer Institute ...
Researchers were pleased to discover that some women with metastatic breast cancer were still alive 10 years after being treated with radiotherapy to the sites where their cancer had spread. The ...
One 80-year-old patient told Wilmot Cancer Institute investigators that he felt 20. A 74-year-old who felt like he was 40 had a goal of outliving his 90-year-old father. But for these vibrant older ...
Wilmot Cancer Institute research shows that giving antibody therapy more often but at lower doses — and perhaps teaching patients how to inject themselves at home — could be a future option for ...
Imagine being at a packed concert hall with a mosh pit full of dancers creating a wall against outsiders. When targeted drugs try to make their way toward a pancreas tumor, they encounter a similar ...
Several chronic lymphocytic leukemia (CLL) patients at the Wilmot Cancer Institute took part in two groundbreaking, nationwide phase 3 studies that are changing the way doctors treat the disease. The ...
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a ...
The National Cancer Institute award $3 million to Supriya Mohile, M.D., for a collaborative, five-year research project stemming from the Beau Biden Cancer Moonshot initiative.
Nearly one in five older patients with advanced cancer have financial problems that may cause them to delay treatment to cover food and housing costs, which leads to stress and poor quality of life, ...
A Wilmot Cancer Institute study revealed the actions of a key gene and its surrounding network that causes cysts in the pancreas, as well as how cancer arises from the cysts. The work could someday ...
While studying a large group of individuals with chronic lymphocytic leukemia (CLL), a Wilmot Cancer Institute scientific team made an important discovery — these patients had a sizable 600 percent ...
For several years, Wilmot Cancer Institute scientist Catherine Ovitt, Ph.D., has been investigating ways to protect and regenerate the salivary gland, which can be damaged during radiation treatment ...
Men with advanced cancer are 30 percent less likely than women to consider palliative care, according to a University of Rochester Medical Center study.
Based on new data from the Wilmot Cancer Institute, researchers now understand more about the gene mutations and risk factors that work together to jump-start the second most common type of liver ...
At the 2018 American Society of Clinical Oncology (ASCO) annual meeting in the coming days, Wilmot Cancer Institute physicians and scientists are presenting data and giving talks on a variety of ...
Supriya G. Mohile, M.D., M.S., an oncologist at the Wilmot Cancer Institute and trailblazer in the growing field of geriatric oncology, has been named the 2018 winner of the B.J. Kennedy Award by the ...
Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study led by Edward M. Messing, ...
The message, “breast is best” may be familiar and powerful, but it’s not enough to get some women to breastfeed. A new University of Rochester Medical Center project creates a partnership with ...
Thanks to a $1 million National Cancer Institute grant, a Wilmot Cancer institute hematologist and oncologist is launching a clinical trial using hyperbaric oxygen therapy to improve the recovery of ...
Because testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in the Journal of Clinical Oncology shows that it’s prudent for patients to ...
Wilmot Cancer Institute patients with advanced melanoma (stage III) now have more options for treatment, thanks to research co-authored by a University of Rochester Medical Center surgical oncologist ...
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer ...
Inflammation in the blood plays a key role in “chemo-brain,” according to a published pilot study that provides evidence for what scientists have long believed.
Wilmot Cancer Institute has a longstanding strength in the study of blood cancers—and from Dec. 9-12, many of our scientists will be presenting research at the 59th annual meeting of the American ...
Talking through bad news can be good for the doctor-patient relationship—debunking a common myth among patients, according to a study co-authored by the University of Rochester Medical Center’s ...
A scientific team at the University of Rochester is using innovative technology to discover preventative treatments for salivary gland radiation damage typical for head and neck cancer patients—and ...
Fifty years ago when Seymour I. Schwartz, M.D., finished writing the first-edition manuscript of a textbook that’s known as the “surgeon’s Bible,” there were no CT scans, no biomarkers, and the most ...
UR Medicine’s Wilmot Cancer Institute will be among the first sites in the world to offer CAR T-cell therapy —a new type of immunotherapy—to adults with aggressive lymphoma. The engineered gene ...
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth ...
Clinical trials to test treatments for chemotherapy-related neuropathy are tricky to conduct, and therefore better study designs would allow scientists to identify beneficial ways to prevent or treat ...
Marshall A. Lichtman, M.D., a University of Rochester hematologist/oncologist and former dean of the School of Medicine and Dentistry, will receive one of the highest honors in his field from the ...
A University of Rochester Medical Center researcher received $1.7 million to study and potentially treat the muscle loss that often plagues childhood cancer survivors as they age.
Patients with advanced cancer who suffer cardiac arrest in the hospital have a survival rate of less than 10 percent — half the rate of other patients without cancer, according to a nationwide study ...
Being deficient in vitamin D has been linked to poorer survival in many cancers, including lymphoma. A new $3 million grant to the Wilmot Cancer Institute allows oncologists to evaluate whether ...
A pathology researcher at the University of Rochester Medical Center believes she’s discovered an important phenomenon in normal-looking breast tissue that could foreshadow an aggressive tumor known ...
They’ve been mistaken for many other types of hospital employees. A few times, patients would only speak to their male counterparts. But when Bianca, Candice, Kristin, and Sandra officially end their ...
The value of eating nuts, the potential of immunotherapy, and the arrival of new precision treatment cocktails were among the many things that Wilmot doctors learned while recently attending the ...
Two junior researchers at the Wilmot Cancer Institute —a post-doctoral associate and a fellow—each won merit awards from the American Society of Clinical Oncology (ASCO) and will be among the ...
The science behind harnessing the immune system to fight cancer is complicated, but a University of Rochester Medical Center laboratory discovered a simple, practical way to use light and optics to ...
The Society of Teachers of Family Medicine (STFM) is honoring Ronald Epstein, M.D., with the 2017 STFM Gold Humanism Award. The award recognizes an STFM member each spring for attributes of humanism ...
Nearly 80 percent of a large group of young men who survived testicular cancer reported having at least one health problem later due to treatment toxicity, says a new Journal of Clinical Oncology ...
Exercise and/or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according to a Wilmot Cancer Institute-led study ...
University of Rochester Medical Center scientists have discovered new essential information about omega 3 fatty acids contained in fish oil and how they could be used for asthma patients.
Ronald Epstein, M.D., a University of Rochester Medical Center professor of Family Medicine, Psychiatry, Oncology, and Medicine, has written the first book for the general public about mindfulness in ...
A clinician/scientist, who studies ways to make cord-blood transplants for leukemia and lymphoma patients safer and more effective, recently reported a new finding in the journal, Blood. An ...
The largest study to date of a condition known as “chemo-brain” shows that women with breast cancer report it’s a substantial problem after chemotherapy for as long as six months after treatment, ...
Researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute in Buffalo reported in the journal Oncotarget, they have discovered a possible new tool for predicting whether ...
University of Rochester Medical Center researchers believe they have identified a potential new means of treating some of the most severe genetic diseases of childhood, according to a study in PLOS ...
Wilmot Cancer Institute physicians and patients were part of a groundbreaking immunotherapy study that’s taking center stage this week in the world of cancer research.
A University of Rochester Medical Center study shows that when tumors are treated with radiotherapy, the benefits can be hijacked by the treatment’s counteraction to also trigger inflammation and ...
Cancer cells have their own unique ways of reproducing, involving a shrewd metabolic reprograming that has been observed in virtually all types of cancer but not in normal cells. Now, University of ...
Specifically training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA ...
A recent study by University of Rochester Medical Center researchers proves why leukemia is so difficult to treat and suggests that the current approach to drug development should be adjusted to ...
Scientists discovered a potential therapy for late-stage liver cancer based on earlier work showing that the androgen receptor (AR), the protein that makes testosterone functional, plays a major role ...
The Wilmot Cancer Institute’s Richard G. Moore, M.D., has identified a gene (HE4) that plays a major role in ovarian cancer, and he recently received a coveted Mary Kay Foundation cancer research ...
Misunderstandings about prognosis between patients with advanced cancer and their doctors was common, in a study reported in JAMA Oncology, and the vast majority of patients didn’t know that their ...
The national Pancreatic Cancer Action Network (PANCAN) granted its most competitive award, for $2 million, to David C. Linehan, M.D., to support a large, multicenter clinical trial testing an ...
Scientists for years have known that the genetic code found in all living things contains many layers of complexity. But new research from the University of Rochester cracks the code more deeply, ...
Researchers at the University of Rochester Wilmot Cancer Institute discovered something simple and inexpensive to reduce neuropathy in hands and feet due to chemotherapy—exercise.
Student-athletes who get a concussion often return to school within a week but still have significant problems in the classroom and cannot perform at a normal academic level, according to a new ...
A new URMC study confirms that androgen deprivation therapy, which initially shrinks aggressive prostate tumors, is a double-edged sword that ultimately might fuel the spread of cancer.
Ed Foster, the first patient to participate in a national clinical trial of a new immunotherapy for lymphoma at the Wilmot Cancer Institute, is healthy enough to be home in Elmira.
The results of an early (phase 1b) clinical trial for pancreatic cancer show that an experimental therapy can control tumors well enough to make some patients eligible for surgery, according to data ...
UR Medicine’s Wilmot Cancer Institute is part of a national clinical trial for an innovative new therapy that involves engineering a patient’s own immune cells to attack cancer, in this case lymphoma.
The cause of Gulf War illness is still a mystery but focusing on treatments and interventions might help the veterans of Operation Desert Storm as well as the troops of the future, according to an ...
The University of Rochester Medical Center announced it’s collaborating with Indivumed, a Germany-based company, to establish a bank of human tissues and tumor samples that are expertly preserved and ...
Researchers at the University of Rochester School of Medicine and Dentistry have developed a new model of cancer in frogs to study how tumors grow, spread, and manipulate immune cells. These ...
A team of Rochester scientists has, for the first time, identified and isolated a stem cell population capable of skull formation and craniofacial bone repair in mice—achieving an important step ...
Dirk Bohmann, Ph.D., an accomplished molecular biologist and scientific leader at the University of Rochester School of Medicine and Dentistry, has been appointed Senior Associate Dean for Basic ...
When patients suffer, doctors tend to want to fix things and if they cannot many doctors then withdraw emotionally. But by turning toward the suffering, physicians can better help their patients and ...
Early life exposures to toxic chemicals such as PCBs and DDT dampen an infant’s response to the tuberculosis vaccine, according to a new study from the University of Rochester Environmental Health ...
Older adults with chronic lymphocytic leukemia may now have an alternative to toxic chemotherapy as their first treatment, according to a national study co-authored by a UR Medicine Wilmot Cancer ...
A University of Rochester biomedical engineering lab discovered a new way to judge whether breast cancer cells are likely to spread, by viewing tumor biopsies with a powerful multi-photon laser ...
University of Rochester Medical Center researcher Richard P. Phipps, Ph.D., won a top scientific award from the pharmaceutical giant Novo Nordisk, to collaborate on a new obesity therapy based on his ...
Hartmut “Hucky” Land, Ph.D., the Robert and Dorothy Markin Professor of Biomedical Genetics at the University of Rochester, received a newly established multimillion dollar award from the National ...
In a 60-site clinical study to investigate whether the drug inosine can slow early Parkinson’s disease, the University of Rochester Medical Center was selected as the coordinating center for data ...
UR Medicine’s Wilmot Cancer Institute is joining the OmniSeq Genomic Network, an organization of institutions being formed to help define the future of advanced genomic diagnostics for cancer. ...
Researchers at UR Medicine’s Wilmot Cancer Institute have developed what they believe to be the first mouse model to investigate why a certain subset of acute myeloid leukemia (AML) patients responds ...
An article led by Ronald M. Epstein, M.D., and published in 2002 is among the top-five most widely cited medical education articles in the last century. Three other manuscripts either authored or ...
The goal for many cancer patients is to reach the five-year, disease-free mark, but new research from UR Medicine’s Wilmot Cancer Institute suggests that two years might be a more practical survival ...
The University of Rochester School of Medicine and Dentistry has received nearly $4 million for a program that would serve as a national model to educate post-doctoral students who are deaf or ...
Scientists at the Wilmot Cancer Institute are working toward doubling the survival rates for pancreatic cancer by 2020—and to help achieve that goal the Pancreatic Cancer Action Network recently ...
Cancer patients might feel their best if they simply maintain or only slightly increase their physical activity throughout chemotherapy instead of letting it decline, according to a University of ...
A new study found that people with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in ...
A University of Rochester Medical Center scientist, who is studying an “all-in-one” agent to be used when breast cancer spreads to the bone, received a $50,000 grant today from the Breast Cancer ...
Do electronic cigarettes help people quit smoking? As the debate continues on that point, a new University of Rochester study suggests that e-cigarettes are likely a toxic replacement for tobacco ...
After more than a decade of development and data-gathering -- including breast scans on nearly 700 women and 79 patents issued -- the U.S. Food and Drug Administration has approved a breast-cancer ...
University of Rochester researchers believe they’re on track to solve the mystery of weight gain – and it has nothing to do with indulging in holiday eggnog.
The message, “when in doubt, sit it out” flashed on video boards throughout the World Series, with good timing: A new analysis of Major League Baseball statistics shows that concussed players may not ...
Armed with a $3.1 million grant from the National Cancer Institute, the Wilmot Cancer Institute is launching the first study ever to test whether a unique yoga therapy can treat insomnia among cancer ...
Michelle C. Janelsins, Ph.D., M.P.H., of UR Medicine’s Wilmot Cancer Institute, has received an NIH Director’s New Innovator Award, the highest honor conferred by the National Institutes of Health ...
Preparing graduate students and post-doctoral trainees for jobs outside of academia is the goal of a new career-training program at the University of Rochester School of Medicine and Dentistry, ...
The Rochester Prevention Research Center (RPRC): National Center for Deaf Health Research (NCDHR) received a $4.35 million award from the Centers for Disease Control and Prevention to continue ...
As a result of longstanding research strength, the Cancer Control & Survivorship program at UR Medicine’s Wilmot Cancer Institute has been selected to receive an $18.6 million, five-year grant for a ...
A majority of middle-aged men and women eligible to take aspirin to prevent heart attack and stroke do not recall their doctors ever telling them to do so, according to a University of Rochester ...
The National Cancer Institute awarded more than $2 million to a team at the Wilmot Cancer Institute to continue its study of a gene network that controls cancer progression, with a focus on ...
Effective July 1, Bruce R. Smoller, M.D., an international leader in the study of skin diseases, will take his place as chair of the Department of Pathology and Laboratory Medicine at the University ...
The Wilmot Cancer Institute announces the opening of UR Medicine’s Comprehensive Breast Care at Pluta. The Henrietta facility will serve as the home for the renowned multidisciplinary breast cancer ...
UR Medicine today announced the creation of the Wilmot Cancer Institute, a new organizational structure for all of its clinical and research programs in cancer, including its growing network of ...
University of Rochester scientists have discovered a gene with a critical link to pancreatic cancer, and further investigation in mice shows that by blocking the gene’s most important function, ...
UR Medicine’s Wilmot Cancer Center is sponsoring its second Warrior Walk in celebration of National Cancer Survivors Day on Sunday, June 1, on the University of Rochester’s River Campus.
Six months off may not be long enough for the brains of football players to completely heal after a single season, putting them at even greater risk of head injury the next season.
Eva K. Pressman, M.D., chair of the Department of Obstetrics and Gynecology and the Henry A. Thiede Professor of Obstetrics and Gynecology, and Seth M. Zeidman, M.D., a neurosurgeon who is a member ...
Doing fewer blood transfusions reduces infection rates by nearly 20 percent, according to a study in the Journal of the American Medical Association co-authored by Neil Blumberg, M.D., professor of ...
Blood transfusions are among the most common treatments for hospitalized patients nationwide, but doing them less often reduces infection rates by nearly 20 percent, according to a study in the ...
Alejandro Zaffaroni, who earned his Ph.D. at the University of Rochester in 1949 and went on to become a world renowned biotechnology entrepreneur and innovator of drug delivery systems, died ...
“Good to see you. I’m sorry. It sounds like you’ve had a tough, tough, week.” Spoken by a doctor to a cancer patient, that statement is an example of compassionate behavior observed by a University ...
The Patient-Centered Outcomes Research Institute (PCORI) approved funding of $2.056 million for a University of Rochester Medical Center team to study how to reduce disparities and improve ...
A team from the University of Rochester Medical Center has shown scientifically what many women report anecdotally: that the breast cancer drug tamoxifen is toxic to cells of the brain and central ...
The nation’s first educational program specifically tailored to deaf and hard-of-hearing people pursuing graduate degrees in biomedical or behavioral science begins Sept. 1 in Rochester, N.Y., a ...
Surgery is often the first step in treating kidney cancer, and new data from the University of Rochester Medical Center, which contradicts earlier research, questions whether removal of only the ...
Patients in moderate to severe pain in emergency rooms across the U.S. are less likely to receive opioid pain medications if they are black, Hispanic, poor, or have less education, compared to more ...
A pair of grants from the American Cancer Society will support two University of Rochester Medical Center researchers to improve patient-centered care and communication; and to gain a better ...
We’ve all known middle-aged people who seem older because of health problems and 75-year-olds who seem younger because they’re very healthy. Scientists want to know if measuring a cancer patient’s ...
The University of Rochester Medical Center has partnered with the Rochester Dermatologic Society and the American Academy of Dermatology to host a free cancer screening on Saturday, May 11 from 8 ...
Tamoxifen is a time-honored breast cancer drug used to treat millions of women with early-stage and less-aggressive disease, and now a University of Rochester Medical Center team has shown how to ...
Even for people diagnosed with asymptomatic, early prostate cancer, the odds that their disease is high- or intermediate-risk and thus more aggressive is increased for people 75 and older and for ...
A University of Rochester M.D. /Ph.D. student won first place in a video contest sponsored by the Orthopaedic Research Society, for a three-minute film using simple images and narration to explain ...
At a major orthopaedics meeting this weekend, researchers from the University of Rochester Medical Center are showcasing studies that merge some of the most significant modern health problems -- ...
University of Rochester Medical Center scientists have proposed a new reason why acute myeloid leukemia, one of the most aggressive cancers, is so difficult to cure.
A New York state law that went into effect Jan. 19, 2013, could impact up to half of all women who get annual mammograms, according to Avice O’Connell, M.D., director of Women’s Imaging at the ...
The University of Rochester Medical Center is launching a large study across upstate New York, in its continuing quest to help cancer patients cope with nausea during chemotherapy by using relaxation ...
A University of Rochester Medical Center analysis of more than 5,300 patients followed for eight months during treatment of spinal disorders showed that cigarette smokers reported far more pain than ...
University of Rochester Medical Center scientists are testing a new approach to speed a patient’s recovery of blood counts during a vulnerable period after a stem-cell transplant, according to a ...
Under certain circumstances neuroticism and conscientiousness can be good for your health, according to a University of Rochester Medical Center study.
Diabetes mellitus is associated with a higher risk of having advanced liver cancer at the time of diagnosis, suggesting that the presence of diabetes may promote more invasive tumor biology, a ...
Documents that explain life-saving medical procedures or how to take part in research can be difficult to understand, but with a $600,000 grant the University of Rochester Medical Center is studying ...
W. Jackson “Jack” Hall, Ph.D., Emeritus Professor of Statistics, Professor in the Department of Biostatistics and Computational Biology, and an international authority on statistical designs for ...
The URMC laboratory of Matthew J. Hilton, which studies the molecular gatekeepers for cartilage development and disease, has an inordinate number of researchers receiving awards and making ...
Judith F. Baumhauer, M.D. M.P.H., winner of the 2012 Rochester Athena Award, was selected from a pool of more than 6,000 past and present Athena award recipients, as one of 30 for special recognition ...
Total knee arthroplasty is one of the most common and costly elective surgeries in the United States, with a volume that soared 162 percent since 1991 among those receiving Medicare benefits, ...
University of Rochester Medical Center scientists discovered new genetic evidence linking cholesterol and cancer, raising the possibility that cholesterol medications could be useful in the future ...
The University of Rochester Medical Center was granted a $7.5 million Center of Research Translation (CORT) award for programs designed to find new therapies for arthritis and bone healing. With a ...
Robert L. Strawderman III, Sc.D., Chair of the Department of Biostatistics and Computational Biology at the University of Rochester Medical Center, has been named Fellow of the Institute of ...
University of Rochester Medical Center scientists believe they are the first to identify genes that underlie the growth of primitive leukemia stem cells; and then to use the new genetic signature to ...
A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission, particularly if the ...
Eliminating the PSA test to screen for prostate cancer would be taking a big step backwards and would likely result in rising numbers of men with metastatic cancer at the time of diagnosis, predicted ...
The University of Rochester Medical Center received a $344,000 state grant for a three-year project to expand and improve training and education of URMC medical students and residents who deliver ...
Even when brain injury is so subtle that it can only be detected by an ultra-sensitive imaging test, the injury might predispose soldiers in combat to post-traumatic stress disorder, according to a ...
About 75 percent of children with leukemia who take chemotherapy face life-threatening heart problems as they age, but an international study led by a University of Rochester Medical Center ...
What is the best way to talk to someone about prognosis and quality of life when serious illness strikes? It turns out that no one had studied that question through direct observation, until the ...
Exercise generally helps the nation’s 12 million cancer survivors, and researchers are working toward being able to prove, with scientific certainty, that prescriptions for daily yoga or 20 minutes ...
The tuberculosis vaccine is often used as a treatment for bladder cancer, and adding vitamin D might improve the vaccine’s effectiveness, according to new research from the University of Rochester ...
Rose Ferrara looks as spry at 97 as some people do at 77, but if a health concern arises outside of a regularly scheduled doctor’s appointment she would rather not leave her comfortable home to get ...
Serious, drug-resistant staph infections are a growing problem in health care in the United States and across the globe. In a coordinated effort to stop these superbugs, investigators from the ...
To honor a 36-year career during which he has mentored more than 50 young professionals in medicine and science, Gary R. Morrow, Ph.D., M.S., today received the Distinguished Research Mentor Award ...
Scattering a gram of powdered antibiotic (vancomycin) directly into a spinal surgery wound appears to be a safe, cost-effective way to achieve low post-operative infection rates, according to a ...
A University of Rochester Medical Center startup company that developed an imaging system to detect breast cancer, announced that it has obtained a key approval from the European Union signaling that ...
The number of cancer survivors in the United States has tripled since 1971 and yet gains in survival have come at the price of second malignancies and cardiovascular disease, according to a ...
Robert L. Strawderman III, Sc.D., professor of Biological Statistics and Computational Biology and Statistical Science at Cornell University, and professor in the Department of Public Health at ...
University of Rochester Medical Center researchers have discovered new links between leukemia cells and cells involved in bone formation, offering a fresh perspective on how the blood cancer ...
Orthopaedic surgeon Judith F. Baumhauer, M.D., M.P.H., professor and associate chair of academic affairs in the Department of Orthopaedics at the University of Rochester Medical Center, today was ...
The University of Rochester Medical Center has been a leader in the study of stereotactic body radiation therapy (SBRT) for the past decade, and three of the latest research projects show that SBRT ...
Regis J. O’Keefe, M.D., Ph.D., chair of the URMC Department of Orthopaedics and Rehabilitation, discusses concerns regarding the use of bisphosphonates for patients with osteoporosis.
Edward M. Schwarz, Ph.D., the Burton Professor of Orthopaedics and Rehabilitation, has been appointed to the additional role of director of URMC’s Center for Musculoskeletal Research (CMSR).
In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop – a well-known and serious complication of cancer treatment – 78 ...
James P. Wilmot Cancer Center researchers had a strong showing among the top presenters at this year’s annual meeting for the American Society of Hematology (ASH), December 10 to 13, in San Diego.
Using communication tools that enabled deaf people to identify health priorities in their own community, a University of Rochester survey found higher rates of obesity, partner violence, and suicide ...
The brain scans of high school football and hockey players showed subtle injury -- even if they did not suffer a concussion – after taking routine hits to the head during the normal course of play, ...
Colleen Fogarty, M.D., jokes that the process of being diagnosed with breast cancer in 2009 was a little too much like a trip to Jiffy Lube, in an essay in which she urges her colleagues to refocus ...
Contrary to common belief, men age 75 and older are diagnosed with late-stage and more aggressive prostate cancer and thus die from the disease more often than younger men, according to a University ...
University of Rochester Medical Center researchers found more evidence that T cells going awry in the microenvironment – or the tissue immediately surrounding the tumor – may play a role in the ...
John C. Elfar, M.D., was awarded the North American Traveling Fellowship by the American Orthopaedic Association, an honor considered to be one of the most exclusive in the field of orthopaedic ...
A medication already approved to build bone mass in patients with osteoporosis also builds cartilage around joints and could potentially be repurposed to treat millions of people suffering from ...
David Hicks, M.D., director of Surgical Pathology at the University of Rochester Medical Center, received a prestigious award Sept. 13, 2011, from the College of American Pathologists (CAP) for his ...
Regis O’Keefe, M.D., Ph.D., chair of the University of Rochester Medical Center Department of Orthopaedics and Rehabilitation, has been appointed to the prestigious NIH Council of Councils.
New data from the University of Rochester Medical Center confirms that an easier, two-drug chemotherapy regimen given to bladder cancer patients prior to surgery shrinks locally advanced tumors and ...
Melanoma is devastating on many fronts: rates are rising dramatically among young people, it is deadly if not caught early, and from a biological standpoint, the disease tends to adapt to even the ...
Judith F. Baumhauer, M.D., M.P.H., has been a trailblazer for years in the field of foot and ankle orthopaedics and today is no different: She was installed as president of the American Orthopaedic ...
The Center for Musculoskeletal Research (CMSR) is conducting its first annual scientific symposium on July 15, in the Flaum Atrium, and the adjacent Class of ’62 Auditorium and Forbes Mezzanine. ...
A large, phase III study of four commonly used drug regimens to treat chemotherapy-induced nausea concluded that while two regimens were better at managing patients’ queasiness, none were totally ...
When an 80-year-old gets cancer, the conventional thinking has been that treatment in most cases would be too risky. A group of geriatric oncologists is pushing a new, national agenda, however, that ...
When John Bennett, M.D., gives the B.J. Kennedy Lecture at the American Society of Clinical Oncology (ASCO) on June 5th -- titled “Cancer and the Older Patient: Let’s Waltz Together” -- he will ...
Treating cancer often represents a double-edged sword, as gains in survival years can be offset by other serious health problems related to the treatment, including second cancers.
A $2.9 million University of Rochester Medical Center research project will test a powerful new intervention to improve the quality of discussions among oncologists, patients, and families in the ...
University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that ...
In the race to more accurately diagnose the severity of head injuries quickly and without a CT scan, a University of Rochester Medical Center expert has a leading role in two important nationwide ...
Low vitamin D levels among women with breast cancer correlate with more aggressive tumors and poorer prognosis, according to a new University of Rochester Medical Center study highlighted this week ...
When a 34-year-old bicyclist was found collapsed on a roadside and rushed to the University of Rochester Medical Center emergency room on the verge of kidney failure and muscle breakdown, doctors ...
High blood pressure, or hypertension, is more common and often more deadly in blacks than in whites, and a new University of Rochester study shows that low vitamin D levels among black people might ...
The National Center for Deaf Health Research (NCDHR) recently won accolades for putting community-based participatory research into action. The NCDHR was one of 11 research groups that won a ...
A special edition of the highly regarded Journal of Clinical Oncology, placed online this week, spotlights James P. Wilmot Cancer Center physicians who write about progress and opportunities in ...
Amin Ismail, Ph.D., a postdoctoral scientist at the James P. Wilmot Cancer Center, is among 50 minority scholars being honored at the American Association for Cancer Research annual meeting, April ...
A mother’s iron deficiency early in pregnancy may have a profound and long-lasting effect on the brain development of the child, even if the lack of iron is not enough to cause severe anemia, ...
Thanks to a group of deaf and hearing Rochester, N.Y., pioneers, a medical journal for the first time has served up a scientific article online with a new twist: an accompanying web video in American ...
Research continues to show that the controversial abortion drug mifepristone might have another use, as a therapeutic option besides hysterectomy for women who suffer from severe symptoms associated ...
University of Rochester Medical Center orthopaedic scientists are a step closer to developing a vaccine to prevent life-threatening methicillin-resistant staphylococcus aureus (MRSA) infections ...
The University of Rochester Medical Center Orthopaedics faculty made a strong showing last week at the Orthopaedics Research Society annual meeting Jan. 13 to 16, 2011, in Long Beach, Calif. Several ...
The University of Rochester and Rochester Institute of Technology have joined forces to bolster two crucial elements of health care reform in the United States—the widespread application of ...
Scientists reported in the journal Nature online that they’ve discovered a new gene mutation that drives activated B cell lymphoma, thereby providing a new route to attempt to stop the dangerous ...
When children are exposed to head and neck radiation, whether due to cancer treatment or multiple diagnostic CT scans, the result is an increased risk of thyroid cancer for the next 58 years or ...
While questions persist about the best ways to detect breast cancer early, a CT imaging system developed at the University of Rochester Medical Center and first unveiled four years ago is in a better ...
The nation’s top scientific advisory panel today recommended that most children and adults modestly increase their intake of vitamin D, known as the “sunshine vitamin,” from a daily dietary intake of ...
A novel project set in a rural community near Rochester, N.Y., to screen elderly people for unmet needs showed that, indeed, there is a great opportunity to match older adults with professional ...
University of Rochester Medical Center orthopaedic researchers have identified a new strategy to make a rare soft tissue tumor more sensitive to chemotherapy, and during the investigation they ...
The University of Rochester Family Medicine residency program was awarded a $1.9 million federal grant, which will add two positions per year for the next five years, in response to a critical ...
Two new vitamin D studies from the University of Rochester Medical Center suggest intriguing ties between a deficiency of D and breast and colon cancer, particularly among African Americans.
Having a family history of breast cancer can lead some people to wonder if their risk is out of their control. However, a study of more than 85,000 postmenopausal women observed that regular physical ...
Scientists have unlocked a strong interaction between two proteins involved in kidney cancer that help to explain the menacing invasiveness of this particular disease, according to a University of ...
The University of Rochester Medical Center once again has received federal bioterrorism funding, allowing investigators to build on several new discoveries made during the past five years to improve ...
As the medical community searches for better vaccines and ways to deliver them, a University of Rochester scientist believes he has discovered a new approach to boosting the body’s response to ...
Two large federal grants received this summer will allow researchers at the James P. Wilmot Cancer Center to continue their work into stem cells that give rise to cancer.
The National Center for Deaf Health Research (NCDHR), at the University of Rochester, is introducing an online resource and referral directory for deaf and hard-of-hearing people, as well as their ...
This week it was announced that blood researchers Neil Blumberg, M.D., and Richard Phipps, Ph.D., at the University of Rochester Medical Center, were among a select group of investigators nationwide ...
Researchers at the University of Rochester Medical Center (URMC) have discovered another reason to filter the foreign white cells from donor blood: the resulting blood product is associated with ...
University of Rochester Medical Center scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as ...
A University of Rochester study helps to explain why men get liver cancer more often than women and opens the door for a new treatment pathway, by showing a direct link between the androgen receptor, ...
Testing for estrogen and progesterone biomarkers following a breast cancer diagnosis is critically important to treatment decisions, yet an international panel that included a University of Rochester ...
A new study that provides a snapshot of a typical American workplace observed that chronic job stress and lack of physical activity are strongly associated with being overweight or obese.
Given the complexity of cancer treatment, skin care may seem like a small matter. However, a nurse at the James P. Wilmot Cancer Center knew that skin issues were a constant source of anxiety for ...
University of Rochester School of Medicine & Dentistry student Tracy L. Fuhrmann was able to complete her education by combining two passions -- dance and medicine -- in a research project that could ...
Joshua C. Munger, Ph.D., an assistant professor of Biochemistry and Biophysics, has received a prestigious Damon Runyon Cancer Research Foundation Innovation Award, which recognizes promising ...
Vitamin D deficiency may contribute to a higher number of heart and stroke-related deaths among black Americans compared to whites, according to a University of Rochester Medical Center study.
Researchers have developed a novel animal model showing that four commonly used chemotherapy drugs disrupt the birth of new brain cells, and that the condition could be partially reversed with the ...
Scientists at the James P. Wilmot Cancer Center who investigate lymphoma and leukemia were among the top presenters at the American Society of Hematology 51st Annual Meeting, Dec. 5-8, 2009, in New ...
A study of 145 preschool children reports, for the first time, that when the concentrations of two common phthalates in mothers’ prenatal urine are elevated their sons are less likely to play with ...
With flu vaccination season in full swing, research from the University of Rochester Medical Center cautions that use of many common pain killers – Advil, Tylenol, aspirin – at the time of injection ...
The University of Rochester Medical Center and its partners in the deaf community are setting out to tackle a common problem – obesity – by using a unique approach.
A Medical Center scientist has been awarded $3.5 million to study how breast cancer cells use collagen fibers to spread, and to investigate whether the process can be predicted and disrupted.
A new study suggests that blood transfusions for hospitalized cardiac patients should be a last resort because they double the risk of infection and increase by nearly five times the risk of death.
Just as it is important to know the stage of cancer at diagnosis, a new study proposes that older people with cancer should be further classified or “staged” into subgroups based on other health ...
The cornerstone of a good doctor-patient relationship begins with the doctor’s ability to clarify a patient’s preferences and values, especially during a difficult diagnosis, a commentary in the ...
A University of Rochester Medical Center researcher sorts out the controversy and promise around a dangerous subtype of cancer cells, known as cancer stem cells.
Doctors who ignore the socioeconomic status of patients when evaluating their risk for heart disease are missing a crucial element that might result in inadequate treatment, according to a University ...
Exposure to dioxins during pregnancy harms the cells in rapidly-changing breast tissue, which may explain why some women have trouble breastfeeding or don’t produce enough milk, according to a ...
Thomas A. Pearson, M.D., M.P.H., Ph.D., the Albert D. Kaiser Professor, Department of Community and Preventive Medicine, and senior associate dean for clinical research at the University of Rochester ...
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history, a University of ...
Families in the Rochester area will be able to take part in the nation’s largest study of the health and well-being of children from birth to age 21, through a multimillion federal grant awarded to ...
Stroke victims tend to do worse if they also have diagnosed or undiagnosed obstructive sleep apnea prior to having the stroke, according to a study presented April 28, 2009, at the American Academy ...
Cancer patients who wore acupressure wristbands had much less nausea while receiving radiation treatment, making the bands a safe, low-cost addition to anti-nausea medication, according to a study in ...
A blood test that can help predict the seriousness of a head injury and detect the status of the blood-brain barrier is a step closer to reality, according to two recently published studies involving ...
The drug rituximab may have an effect against follicular lymphoma (FL) similar to that of a vaccine against the flu, which may help to explain why the drug continues to work in some people long after ...
People who suffer an ischemic stroke and also have an abnormality in the heart’s electrical cycle are at a higher risk of death within 90 days than people who do not have abnormal electrical activity ...
THIS LECTURE IS CANCELLED. David Blumenthal, M.D., M.P.P., a key health care advisor to President Barack Obama during the 2008 campaign, will speak at the University of Rochester Medical Center on ...
When an emergency squad pulls up to the home of an elderly person in distress in upstate New York, chances are the paramedics have received a new brand of high-tech training using a video podcast, ...
In a collaborative study published Feb. 9, 2009, in the Proceedings of the National Academy of Sciences (PNAS), scientists performed a genome-wide expression analysis comparing highly enriched normal ...
A University of Rochester Medical Center study challenges common assumptions about the chemical bisphenol A (BPA), by showing that in some people, surprisingly high levels remain in the body even ...